IP Verse

Adaptimmune competitive analysis

Loading summary...

Latest oppositions filed by Adaptimmune

Explore patent oppositions filed by Adaptimmune against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3236985
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other CancersIMMATICS BIOTECHNOLOGIESJun 25, 2020

Latest patents of Adaptimmune opposed by its competitors

Explore Adaptimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4017984
Oct 2, 2024Lentiviral Transduction Methods1
EP3373013
Jul 19, 2023Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3
EP3440104
Jun 14, 2023T Cell Receptors1
EP3060668
Oct 19, 2022Vectors For Transgene Expression1
EP3116901
Jun 12, 2019Tcr Libraries1
EP2936158
Feb 13, 2019Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3

Latest publications and patents of Adaptimmune New

Explore the latest publications and patents granted to Adaptimmune, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Adaptimmune

EP4017984
Oct 2, 2024Lentiviral Transduction MethodsGranted And Under Opposition
EP3373013
Jul 19, 2023Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexGranted And Under Opposition
EP3440104
Jun 14, 2023T Cell ReceptorsPatent Maintained As Amended
EP3060668
Oct 19, 2022Vectors For Transgene ExpressionPatent Maintained As Amended
EP3116901
Jun 12, 2019Tcr LibrariesRevoked
EP2936158
Feb 13, 2019Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexRevoked

Latest PTAB cases involving Adaptimmune

Discover the latest PTAB cases involving Adaptimmune, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adaptimmune with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ADAPTIMMUNE110 - -
DR H ULRICH DORRIES26 - - -
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT8 - - -
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB27 - - -